Sign in

CIK 0001561921

  • Non-accelerated filer
  • Smaller reporting company

TELA Bio, Inc.

Sign in to watch
Ticker
TELA
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
455320061
Phone
+1 484-320-2930
Business address
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA, 19355
  1. 4 Open-market buy 10% owner bought 3,567 shares at an average $7.00 ($24,969)
  2. 4 Open-market buy EW HEALTHCARE PARTNERS FUND 2, L.P. bought 15,000 shares at an average $7.14 ($107,050)
  3. 4 Open-market buy 10% owner bought 2,400 shares at $6.99 ($16,776)
  4. 4 Open-market buy EW HEALTHCARE PARTNERS FUND 2, L.P. bought 15,000 shares at an average $6.84 ($102,600)
  5. 4 Other disposition 10% owner disposed of 1,751,100 shares (other)
  6. 4 Open-market buy 10% owner bought 52,400 shares at $6.50 ($340,574)
  7. 4 Open-market buy EW HEALTHCARE PARTNERS FUND 2, L.P. bought 15,000 shares at an average $6.14 ($92,150)
  8. 4 Open-market buy EW HEALTHCARE PARTNERS FUND 2, L.P. bought 15,000 shares at an average $5.86 ($87,850)
  9. 4 Open-market buy 10% owner bought 27,500 shares at $5.60 ($154,066)
  10. 4 Open-market buy EW HEALTHCARE PARTNERS FUND 2, L.P. bought 15,000 shares at an average $5.98 ($89,750)
  11. 4 Open-market buy EW HEALTHCARE PARTNERS FUND 2, L.P. bought 15,000 shares at an average $6.13 ($91,900)
  12. 4 Open-market buy COO and CFO bought 15,000 shares at $5.50 ($82,500)
  13. 4 Open-market buy EW HEALTHCARE PARTNERS FUND 2, L.P. bought 15,000 shares at an average $6.99 ($104,900)
  14. 4 Grant or award Director acquired 3,135 shares (grant or award)
  15. 4 Grant or award Director acquired 3,135 shares (grant or award)
  16. 4 Grant or award Director acquired 3,135 shares (grant or award)
  17. 4 Grant or award Director acquired 3,135 shares (grant or award)
  18. 4 Grant or award Director acquired 3,135 shares (grant or award)
  19. 4 Grant or award Director acquired 3,135 shares (grant or award)
  20. 4 Open-market buy EW HEALTHCARE PARTNERS FUND 2, L.P. bought 15,000 shares at an average $7.11 ($106,700)

Page 7 of 14 · 271 filings